
Mazindol - Wikipedia
Mazindol, sold under the brand names Mazanor and Sanorex, is a central nervous system (CNS) stimulant which is used as an appetite suppressant. [2] It was developed by Sandoz-Wander in the 1960s. [ 3 ]
Mazindol Uses, Side Effects & Warnings - Drugs.com
Mazindol stimulates the central nervous system (nerves and brain), which increases your heart rate and blood pressure and decreases your appetite. Mazindol is used as a short-term supplement to diet and exercise in the treatment of obesity.
Mazindol: Uses, Interactions, Mechanism of Action - DrugBank …
Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Mazindol ¿Qué es y Para qué Sirve? Dosis - QuéFarmacia
2022年12月12日 · Mazindol es un medicamento anorexígeno, que se usa como complemento de la dieta y el ejercicio a corto plazo para disminuir el apetito y así facilitar la pérdida de peso. Por lo tanto, está indicado para el tratamiento de: Obesidad.
Mazindol Side Effects: Common, Severe, Long Term - Drugs.com
If you experience any of the following serious side effects, stop taking mazindol and seek emergency medical attention: an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
Mazindol - an overview | ScienceDirect Topics
Mazindol (Teronac®) is an imidazoline derivative which blocks dopamine and norepinephrine reuptake and is active against EDS and cataplexy. From: Handbook of Clinical Neurology, 2013
Mazindol | C16H13ClN2O | CID 4020 - PubChem
It is a Stimulants substance. Mazindol is a tricyclic anorexigenic agent that is unrelated to and less toxic than [amphetamine], but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Mazindol Demonstrates Safety Profile in Narcolepsy Treatment
2023年6月15日 · Mazindol is a triple monoamine reuptake inhibitor and partial orexin-2 receptor agonist, which was used for many years to treat patients diagnosed with narcolepsy in compassionate use programs.
Phase 3 Trial of Mazindol ER for Narcolepsy to Begin
2023年7月6日 · The AMAZE program will encompass two almost-identical double-blind phase 3 studies (N=50 each) investigating mazindol ER versus placebo in adult patients with narcolepsy, commencing this summer at multiple sites exclusively in the United States.
Mazindol : Indications, Uses, Dosage, Drugs Interactions, Side …
Mazindol is a tricyclic anorexigenic agent belonging to central nervous system (CNS) stimulants. medication that is primarily used to treat obesity. Mazindol is Readily absorbed from the GI tract. It gets excreted Via urine (as metabolite and unchanged drug).
- 某些结果已被删除